Table E2.
Comparison of unadjusted outcomes of treatment groups
| Concomitant | Early-Staged | Late-Staged | P value | |
|---|---|---|---|---|
| Mortality | 0.79 | 1.89 | 1.62 | .34 |
| Stroke | 1.76 | 2.88 | 2.54 | .50 |
| Post-procedural hemorrhage | 0.63 | 1.42 | 0.96 | .39 |
| Blood transfusion | 8.11 | 11.8 | 8.83 | .15 |
| Acute kidney injury | 6.32 | 27.5∗ | 12.5∗ | <.001 |
| Pacemaker implantation | 12.4 | 16.7 | 12.0 | .044 |
| Non-home discharge | 30.1 | 62.4∗ | 55.8∗ | <.001 |
| Median post-TAVR length of stay (IQR), d | 2 (1-3) | 3 (2-6) | 2 (2-4) | <.001 |
| Median total length of stay (IQR), d | 2 (1-3) | 11 (6-17)∗ | 8 (5-13)∗ | <.001 |
| Median total hospitalization costs per $1000 (IQR) | 55.6 (43.9-70.7) | 75.8 (60.8-95.4)∗ | 73.4 (58.0-93.7)∗ | <.001 |
| 30-Day readmission | 10.9 | 19.6∗ | 15.4∗ | .003 |
Data are reported as percentages unless otherwise noted. TAVR, Transcatheter aortic valve replacement; IQR, interquartile range.
∗
Denotes P < .025 on pairwise comparison with Concomitant as reference.